BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 3509344)

  • 21. Pentagastrin analogues containing alpha-aminooxy acids. VII. Catabolism in vivo and in vitro of a pentagastrin analogue containing N-terminal aminooxyacetyl residue.
    Varga L; Holzinger G; Németh J; Varró V; Baláspiri L; Szabó I; Schön I; Kisfaludy L
    Acta Med Hung; 1983; 40(4):259-70. PubMed ID: 6674919
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The use of topographical constraints in receptor mapping: investigation of the topographical requirements of the tryptophan 30 residue for receptor binding of Asp-Tyr-D-Phe-Gly-Trp-(N-Me)Nle-Asp-Phe-NH2 (SNF 9007), a cholecystokinin (26-33) analogue that binds to both CCK-B and delta-opioid receptors.
    Boteju LW; Nikiforovich GV; Haskell-Luevano C; Fang SN; Zalewska T; Stropova D; Yamamura HI; Hruby VJ
    J Med Chem; 1996 Sep; 39(20):4120-4. PubMed ID: 8831778
    [TBL] [Abstract][Full Text] [Related]  

  • 23. CCK-A-selective tetrapeptides containing lys(N epsilon)-amide residues: favorable in vivo and in vitro effects of N-methylation at the aspartyl residue.
    Bennett MJ; Nikkel AL; Bianchi BR; Miller TR; Bednarz L; Witte DG; Stashko M; Wang SS; Gore PA; Asin KE
    J Med Chem; 1994 May; 37(11):1569-71. PubMed ID: 8201591
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Cholecystokinin-pancreozymin synthesis. Synthesis of [28-threonine,31-norleucine]- and [28-threonine,31-leucine]cholecystokinin-pancreozymin-(25-33)-nonapeptide].
    Moroder L; Wilschowitz L; Gemeiner M; Göhring W; Knof S; Scharf R; Thamm P; Gardner JD; Solomon TE; Wünsch E
    Hoppe Seylers Z Physiol Chem; 1981 Jul; 362(7):929-42. PubMed ID: 7275014
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Synthesis and biological activities of some human gastrin analogs.
    Lima-Leite AC; Fulcrand P; Galleyrand JC; Berge G; Aumelas A; Bali JP; Castel J; Martinez J
    Braz J Med Biol Res; 1996 Oct; 29(10):1253-63. PubMed ID: 9181094
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Novel activity of angiotensin-converting enzyme. Hydrolysis of cholecystokinin and gastrin analogues with release of the amidated C-terminal dipeptide.
    Dubreuil P; Fulcrand P; Rodriguez M; Fulcrand H; Laur J; Martinez J
    Biochem J; 1989 Aug; 262(1):125-30. PubMed ID: 2554881
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pharmacological profile of a new peptidic gastrin antagonist.
    Lavezzo A; Bali JP; Magous R; Lignon MF; Nisato D; Laur J; Castro B; Martinez J
    Regul Pept; 1986 Sep; 15(2):111-9. PubMed ID: 3786833
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Synthetic analogs of cholecystokinin terminal tetrapeptide that stimulate insulin but not glucagon release from pancreatic islets.
    Khalid P; Sharma SD; Khan MM; Rastogi AK; Kidwai JR; Mathur KB
    Acta Diabetol Lat; 1986; 23(3):239-42. PubMed ID: 3538737
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Novel CCK analogues and bombesin: a detailed analysis between phosphoinositide breakdown and high-dose inhibition of pancreatic enzyme secretion in three rodent species.
    Bianchi BR; Miller TR; Witte DG; Lin CW
    J Pharmacol Exp Ther; 1994 Feb; 268(2):996-1002. PubMed ID: 7509394
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Synthesis of Z-CCK-27-32-NH2, Z-Tyr(SO-3)-Met-Gly-Trp-Met-Asp-NH2, a cholecystokinin receptor antagonist and an inhibitor of gastrin-induced acid secretion.
    Briet C; Aumelas A; Martinez J
    Int J Pept Protein Res; 1985 Sep; 26(3):294-8. PubMed ID: 2997059
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Analogues of growth hormone-releasing factor (1-29) amide containing the reduced peptide bond isostere in the N-terminal region.
    Hocart SJ; Murphy WA; Coy DH
    J Med Chem; 1990 Jul; 33(7):1954-8. PubMed ID: 2141879
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Formation of aminosuccinyl derivative from beta-phenacyl aspartyl peptides catalyzed by sodium thiophenoxide.
    Gaudreau P; Morell JL; Gross E
    Int J Pept Protein Res; 1982 Mar; 19(3):280-3. PubMed ID: 7118398
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Structure-based design of new constrained cyclic agonists of the cholecystokinin CCK-B receptor.
    Blommaert AG; Dhôtel H; Ducos B; Durieux C; Goudreau N; Bado A; Garbay C; Roques BP
    J Med Chem; 1997 Feb; 40(5):647-58. PubMed ID: 9057851
    [TBL] [Abstract][Full Text] [Related]  

  • 34. CCK-A receptor selective antagonists derived from the CCK-A receptor selective tetrapeptide agonist Boc-Trp-Lys(Tac)-Asp-MePhe-NH2 (A-71623).
    Sugg EE; Kimery MJ; Ding JM; Kenakin DC; Miller LJ; Queen KL; Rimele TJ
    J Med Chem; 1995 Jan; 38(1):207-11. PubMed ID: 7837233
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Phylogeny of the cholecystokinin/gastrin family.
    Johnsen AH
    Front Neuroendocrinol; 1998 Apr; 19(2):73-99. PubMed ID: 9578981
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Conformationally readdressed CCK-B/delta-opioid peptide ligands.
    Nikiforovich GV; Kolodziej SA; Nock B; Bernad N; Martinez J; Marshall GR
    Biopolymers; 1995 Oct; 36(4):439-52. PubMed ID: 7578939
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Aromatic interactions in tryptophan-containing peptides: crystal structures of model tryptophan peptides and phenylalanine analogs.
    Sengupta A; Mahalakshmi R; Shamala N; Balaram P
    J Pept Res; 2005 Jan; 65(1):113-29. PubMed ID: 15686542
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Biological and conformational examination of stereochemical modifications using the template melanotropin peptide, Ac-Nle-c[Asp-His-Phe-Arg-Trp-Ala-Lys]-NH2, on human melanocortin receptors.
    Haskell-Luevano C; Nikiforovich G; Sharma SD; Yang YK; Dickinson C; Hruby VJ; Gantz I
    J Med Chem; 1997 May; 40(11):1738-48. PubMed ID: 9171884
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Stimulation of insulin secretion by peptides analogous to the C-terminal tetrapeptide amide of cholecystokinin.
    Ahmad N; Sharma SD; Rastogi AK; Kidwai JR; Mathur KB
    Acta Diabetol Lat; 1984; 21(4):361-4. PubMed ID: 6397026
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effect of a gastrin/cholecystokinin B receptor antagonist, S-0509, on the omeprazole-induced proliferation of gastric mucosa in rats.
    Ono M; Sato H; Kazumori H; Yuki M; Rumi MA; Ortega-Cava CF; Ishihara Y; Ishihara S; Adachi K; Kinoshita Y
    J Lab Clin Med; 2003 Dec; 142(6):364-71. PubMed ID: 14713888
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.